Back to Search Start Over

687P A CRUK phase I/IIA, first in human dose-escalation and expansion trial of HMBD-001 (an anti-HER3 antibody) in patients with advanced HER3 positive solid tumours.

Authors :
de Bono, J.S.
Lord, S.
Yap, C.
Miranda, S.
Veal, G.J.
Chandran, K.
Paschalis, A.
Peron, C.
Rekowski, J.
Gurel, B.
Paisley, D.
McGuigan, L.
Ingram, P.J.
Kwek, K.Y.
Halbert, G.
Westwood, N.B.
Griffin, A.E.
Kostaras, L.
Boyd-Kirkup, J.D.
Walter, H.S.
Source :
Annals of Oncology. 2023 Supplement 2, Vol. 34, pS479-S480. 2p.
Publication Year :
2023

Subjects

Subjects :
*IMMUNOGLOBULINS
*TUMORS
*HUMAN beings

Details

Language :
English
ISSN :
09237534
Volume :
34
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
173098742
Full Text :
https://doi.org/10.1016/j.annonc.2023.09.1873
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details